Vorhofflimmern bei Patienten mit Herzinsuffizienz

Schlüsselwörter

Vorhofflimmern - Herzinsuffizienz - Pathophysiologie - Therapie

Keywords

atrial fibrillation - heart failure - pathophysiology - therapy

Literatur

• 1 Alsheikh-Ali A A, Wang P J, Rand W. et al . Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.  Am Heart J. 2004;  147 1061-1065
• 2 Boldt A, Scholl A, Garbade J. et al . ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.  Basic Res Cardiol. 2006;  101 261-267
• 3 Boldt L H, Rolf S, Huemer M. et al . Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.  Am Heart J. 2008;  155 890-895
• 4 Brignole M, Gammage M, Puggioni E. et al . Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation.  Eur Heart J. 2005;  26 712-722
• 5 Cappato R, Calkins H, Chen S A. et al . Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.  Circulation. 2005;  111 1100-1105
• 6 Cardin S, Li D, Thorin-Trescases N, Leung T K, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.  Cardiovasc Res. 2003;  60 315-325
• 7 Chang S L, Chen Y C, Chen Y J. et al . Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins.  Heart. 2007;  93 82-88
• 8 Chen M S, Marrouche N F, Khaykin Y. et al . Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.  J Am Coll Cardiol. 2004;  43 1004-1009
• 9 Clark D M, Plumb V J, Epstein A E, Kay G N. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.  JACC. 1997;  30 1039-1045
• 10 Cleland J G, Daubert J C, Erdmann E. et al . The effect of cardiac resynchronization on morbidity and mortality in heart failure.  N Engl J Med. 2005;  352 1539-1549
• 11 Corley S D, Epstein A E, DiMarco J P. et al . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.  Circulation. 2004;  109 1509-1513
• 12 Corradi D, Callegari S, Benussi S. et al . Regional left atrial interstitial remodelling in patients with chronic atrial fibrillation undergoing mitral-valve surgery.  Virchows Arch. 2004;  445 498-505
• 13 Crijns H J, Tjeerdsma G, de Kam P J. et al . Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.  Eur Heart J. 2000;  21 1238-1245
• 14 Doshi R N, Daoud E G, Fellows C. et al . Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).  J Cardiovasc Electrophysiol. 2005;  16 1160-1165
• 15 Dries D L, Exner D V, Gersh B J. et al . Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD Trials.  J Am Coll Cardiol. 1998;  32 695-703
• 16 Ducharme A, Swedberg K, Pfeffer M A. et al . Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.  Am Heart J. 2006;  152 86-92
• 17 Fuster V, Rydén L E, Cannom D S. et al . ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.  Circulation. 2006;  114 e257-e354
• 18 Gasparini M, Auricchio A, Regoli F. et al . Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.  J Am Coll Cardiol. 2006;  48 (4) 734-743
• 19 Gentlesk P J, Sauer W H, Gerstenfeld E P. et al . Reversal of left ventricular dysfunction following ablation of atrial fibrillation.  J Cardiovasc Electrophysiol. 2007;  18 9-14
• 20 Goette A, Breithardt G, Fetsch T. et al . Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design.  Clin Drug Investig. 2007;  27 697-705
• 21 Goette A, Staack T, Röcken C. et al . Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.  J Am Coll Cardiol. 2000;  35 1669-1677
• 22 Grönefeld G C, Mauss O, Li Y G, Klingenheben T, Hohnloser S H. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study.  J Cardiovasc Electrophysiol. 2000;  11 1208-1214
• 23 Hanna N, Cardin S, Leung T K. et al . Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.  Cardiovasc Res. 2004;  63 236-244
• 24 Haverkamp W, Mönnig G, Schulze-Bahr E, Haverkamp F, Breithardt G. Physician-induced torsade de pointes – therapeutic implications.  Cardiovasc Drugs Ther. 2002;  16 101-109
• 25 Hsu L F, Jais P, Sanders P. et al . Catheter ablation for atrial fibrillation in congestive heart failure.  N Engl J Med. 2004;  351 2373-2383
• 26 Kuijpers N H, ten Eikelder H M, Bovendeerd P H, Verheule S, Arts T, Hilbers P A. Mechanoelectric feedback leads to conduction slowing and block in acutely dilated atria: a modeling study of cardiac electromechanics.  Am J Physiol Heart Circ Physiol. 2007;  292 H2832-2853
• 27 Leclercq C, Walker S, Linde C. et al . Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.  Eur Heart J. 2002;  22 1780-1787
• 28 Leon A R, Greenberg J M, Kanuru N. et al . Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.  J Am Coll Cardiol. 2002;  39 1258-1263
• 29 Li D, Fareh S, Leung T K, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodelling of a different sort.  Circulation. 1999;  100 87-95
• 30 Madrid A H, Bueno M G, Rebollo J M. et al . Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.  Circulation. 2002;  106 331-336
• 31 Maggioni A P, Latini R, Carson P E. et al . Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).  Am Heart J. 2005;  149 548-557
• 32 Maisel W H, Stevenson L W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.  Am J Cardiol. 2003;  91 2D-8D
• 33 Middlekauff H R, Stevenson W G, Stevenson L W. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients.  Circulation. 1991;  84 40-48
• 34 Nasr I A, Bouzamondo A, Hulot J S, Dubourg O, Le H euzey JY, Lechat P. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.  Eur Heart J. 2007;  28 457-462
• 35 Pasic M, Bergs P, Müller P. et al . Intraoperative radiofrequency maze ablation for atrial fibrillation: the Berlin modification.  Ann Thorac Surg. 2001;  72 1484-1490
• 36 Pedersen O D, Abildstrøm S Z, Ottesen M M. et al . Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.  Eur Heart J. 2006;  27 290-295
• 37 Pedersen O D, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.  Circulation. 1999;  100 376-380
• 38 Pedersen O D, Søndergaard P, Nielsen T. et al . Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure.  Eur Heart J. 2006;  27 2866-2870
• 39 Rathore S S, Curtis J P, Wang Y, Bristow M R, Krumholz H M. Association of serum digoxin concentration and outcomes in patients with heart failure.  JAMA. 2003;  289 871-878
• 40 Rienstra M, Smit M D, Nieuwland W. et al . Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.  Am Heart J. 2007;  153 120-126
• 41 Roy D, Talajic M, Nattel S. et al . Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure.  N Engl J Med. 2008;  358 2667-2677
• 42 Ryan S, Siemon G, Drögemüller A. et al . 2 year follow-up of 321 patients with an implantable cardioverter/defibrillator: comparison of patients with and without atrial fibrillation.  Z Kardiol. 2001;  90 906-915
• 43 Shi Y, Li D, Tardif J C, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.  Cardiovasc Res. 2002;  54 456-461
• 44 Sie H T, Beukema W P, Elvan A, Ramdat M isier AR. Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience.  Ann Thorac Surg. 2004;  77 512-516
• 45 Swedberg K, Olsson L G, Charlesworth A. et al . Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.  Eur Heart J. 2005;  26 1303-1308
• 46 Sweeney M O, Hellkamp A S, Ellenbogen K A. et al . Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.  Circulation. 2003;  107 2932-2937
• 47 Ueng K C, Tsai T P, Yu W C. et al . Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study.  Eur Heart J. 2003;  24 2090-2098
• 48 Van Gelder I C, Hagens V E, Bosker H A. et al, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group . A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.  N Engl J Med. 2002;  347 1834-1840
• 49 Vermes E, Tardif J C, Bourassa M G. et al . Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.  Circulation. 2003;  107 2926-2931
• 50 Wyse D G, Waldo A L, DiMarco J P. et al, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators . Comparison of rate control and rhythm control in patients with atrial fibrillation.  N Eng J Med. 2002;  347 1825-1833